SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹50 Cr | ₹1.12 Cr | ₹1.44 Cr | ₹0.73 Cr | ₹0.75 Cr |
What is the latest Contingent Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹1.12 Cr |
| Mar2023 | ₹1.44 Cr |
| Mar2022 | ₹0.73 Cr |
| Mar2021 | ₹0.75 Cr |
How is Contingent Liabilities of SYSCHEM (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 4,385.17 | |
| Mar2024 | ₹1.12 Cr | -22.29 | |
| Mar2023 | ₹1.44 Cr | 98.62 | |
| Mar2022 | ₹0.73 Cr | -3.07 | |
| Mar2021 | ₹0.75 Cr | - | |
Compare Contingent Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹211.0 Cr | -3.1% | -15.5% | 12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -3.1% |
-15.5% |
12.5% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses